2017 Form 10-K Financial Statement

#000119312518097812 Filed on March 27, 2018

View on sec.gov

Income Statement

Concept 2017 2016 Q4
Revenue $15.14M $0.00
YoY Change
Cost Of Revenue $16.60M
YoY Change
Gross Profit -$1.455M
YoY Change
Gross Profit Margin -9.61%
Selling, General & Admin $4.088M
YoY Change 171664.71%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.991M
YoY Change
% of Gross Profit
Operating Expenses $1.738M $2.376K
YoY Change 72924.24%
Operating Profit -$11.53M -$2.376K
YoY Change
Interest Expense $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income $508.8K -$2.376K
YoY Change -21476.81%
Income Tax $7.041M
% Of Pretax Income 1383.93%
Net Earnings -$187.1K -$2.376K
YoY Change 7761.68%
Net Earnings / Revenue -1.24%
Basic Earnings Per Share -$0.30
Diluted Earnings Per Share -$0.30
COMMON SHARES
Basic Shares Outstanding 62.26M shares
Diluted Shares Outstanding 62.26M shares

Balance Sheet

Concept 2017 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $479.1K
YoY Change 6287.47%
Cash & Equivalents $0.00
Short-Term Investments
Other Short-Term Assets $67.48K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $546.5K $7.500K
YoY Change 7187.07%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $379.2M
YoY Change
Other Assets $0.00
YoY Change -100.0%
Total Long-Term Assets $379.2M $38.23K
YoY Change 991730.68%
TOTAL ASSETS
Total Short-Term Assets $546.5K $7.500K
Total Long-Term Assets $379.2M $38.23K
Total Assets $379.7M $45.73K
YoY Change 830259.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $742.7K
YoY Change 23780.71%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.248M $23.11K
YoY Change 5298.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $13.21M
YoY Change
Total Long-Term Liabilities $13.21M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.248M $23.11K
Total Long-Term Liabilities $13.21M
Total Liabilities $14.45M $23.11K
YoY Change 62443.7%
SHAREHOLDERS EQUITY
Retained Earnings -$2.376K
YoY Change
Common Stock $23.99K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $365.3M $59.34M
YoY Change
Total Liabilities & Shareholders Equity $379.7M $45.73K
YoY Change 830259.5%

Cashflow Statement

Concept 2017 2016 Q4
OPERATING ACTIVITIES
Net Income -$187.1K -$2.376K
YoY Change 7761.68%
Depreciation, Depletion And Amortization $5.991M
YoY Change
Cash From Operating Activities $0.00
YoY Change -100.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities $0.00
Cash From Investing Activities $0.00
Cash From Financing Activities $0.00
Net Change In Cash $0.00
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities $0.00
Capital Expenditures $0.00
Free Cash Flow $0.00
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 dei Entity Public Float
EntityPublicFloat
378000000
CY2016Q4 us-gaap Shares Outstanding
SharesOutstanding
0 shares
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
0
CY2016Q4 us-gaap Assets Current
AssetsCurrent
7500
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
23994
CY2016Q4 us-gaap Assets
Assets
45734
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7500
CY2016Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
38234
CY2016Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2016Q4 us-gaap Liabilities
Liabilities
23110
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45734
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
23110
CY2016Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
20000
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2376
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
22624
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2016Q4 kaac Accrued Formation And Offering Costs Current
AccruedFormationAndOfferingCostsCurrent
3110
CY2017Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
304876
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
742688
CY2017Q4 us-gaap Assets Current
AssetsCurrent
546534
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5188377
CY2017Q4 us-gaap Assets
Assets
379723399
CY2017Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
379176865
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
479055
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2017Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
13206239
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
522985
CY2017Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2017Q4 us-gaap Liabilities
Liabilities
14453853
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
379723399
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1247614
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
67479
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-189484
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
5000006
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2017Q4 kaac Redemption Limitation Minimum Net Tangible Assets
RedemptionLimitationMinimumNetTangibleAssets
5000001
CY2017Q4 kaac Accrued Franchise Taxes Current
AccruedFranchiseTaxesCurrent
200050
CY2017Q4 kaac Deferred Tax Assets General And Administrative Expenses
DeferredTaxAssetsGeneralAndAdministrativeExpenses
322965
CY2017Q4 kaac Tax Cuts And Jobs Act Of2017 Change In Tax Rate Deferred Tax Asset Valuation Allowance
TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetValuationAllowance
322965
CY2016Q4 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7500
CY2016Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2016Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2376
CY2016Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2376
CY2016Q4 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2376
CY2016Q4 us-gaap Operating Expenses
OperatingExpenses
2376
CY2016Q4 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
9876
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-2376
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2376
CY2016Q4 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
35124
CY2016Q4 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
20000
CY2016Q4 us-gaap Revenues
Revenues
0
CY2016Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10062500 shares
CY2016Q4 kaac Deferred Underwriting Compensation And Offering Costs
DeferredUnderwritingCompensationAndOfferingCosts
3110
CY2016Q4 kaac Sale Of Common Stock To Sponsors Value
SaleOfCommonStockToSponsorsValue
25000
CY2016Q4 kaac Sale Of Common Stock To Sponsors Price Per Shares
SaleOfCommonStockToSponsorsPricePerShares
0.001
CY2017 dei Amendment Flag
AmendmentFlag
false
CY2017 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
21433512
CY2017 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 2%; MARGIN-TOP: 18pt"> <b><i>Concentration of Credit Risk</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p> </div>
CY2017 us-gaap Common Stock Voting Rights
CommonStockVotingRights
Holders of the Company's common stock are entitled to one vote for each share of common stock.
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
471555
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
695876
CY2017 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.37 pure
CY2017 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2017 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017 dei Document Type
DocumentType
10-K
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
508768
CY2017 us-gaap Earnings Per Share Potentially Dilutive Securities
EarningsPerSharePotentiallyDilutiveSecurities
At December 31, 2016, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company under the treasury stock method.
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2017 dei Document Period End Date
DocumentPeriodEndDate
2017-12-31
CY2017 dei Entity Registrant Name
EntityRegistrantName
Kayne Anderson Acquisition Corp
CY2017 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2017 dei Entity Central Index Key
EntityCentralIndexKey
0001692787
CY2017 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2017 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2017 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1537927
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
391000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
172891
CY2017 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
1244504
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
67479
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-865828
CY2017 us-gaap Operating Expenses
OperatingExpenses
1737977
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
378658503
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-187108
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-1737977
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2246745
CY2017 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
642617
CY2017 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
7546422
CY2017 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
245000
CY2017 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
9546422
CY2017 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
377321120
CY2017 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
265000
CY2017 us-gaap Revenues
Revenues
0
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
377321120
CY2017 dei Trading Symbol
TradingSymbol
KAAC
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10682217 shares
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 2%; MARGIN-TOP: 18pt"> <b><i>Use of Estimates</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The preparation of financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
CY2017 kaac Franchise Tax Expense
FranchiseTaxExpense
200050
CY2017 kaac Cash Deposited In Trust Account
CashDepositedInTrustAccount
377321120
CY2017 kaac Sale Of Private Placement Warrants
SaleOfPrivatePlacementWarrants
9546422
CY2017 kaac Number Of Private Placement Warrants
NumberOfPrivatePlacementWarrants
6364281 shares
CY2017 kaac Private Placement Warrants Price Per Share
PrivatePlacementWarrantsPricePerShare
1.5
CY2017 kaac Shares Subject To Possible Redemption Amount
SharesSubjectToPossibleRedemptionAmount
360269540
CY2017 kaac Estimated Federal Income Tax Payment
EstimatedFederalIncomeTaxPayment
391000
CY2017 kaac Deferred Underwriting Compensation And Offering Costs
DeferredUnderwritingCompensationAndOfferingCosts
13206239
CY2017 kaac Tax Cuts And Jobs Act Of2017 Incomplete Accounting Tax Rate Effect Of Tax Law Changes In Period Of Enactment Percent
TaxCutsAndJobsActOf2017IncompleteAccountingTaxRateEffectOfTaxLawChangesInPeriodOfEnactmentPercent
0.21 pure
CY2017 kaac Other Nonoperating Income Expense Net Of Tax
OtherNonoperatingIncomeExpenseNetOfTax
1855745
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0

Files In Submission

Name View Source Status
0001193125-18-097812-index-headers.html Edgar Link pending
0001193125-18-097812-index.html Edgar Link pending
0001193125-18-097812.txt Edgar Link pending
0001193125-18-097812-xbrl.zip Edgar Link pending
d508785d10k.htm Edgar Link pending
d508785dex109.htm Edgar Link pending
d508785dex311.htm Edgar Link pending
d508785dex312.htm Edgar Link pending
d508785dex321.htm Edgar Link pending
d508785dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kaac-20171231.xml Edgar Link completed
kaac-20171231.xsd Edgar Link pending
kaac-20171231_cal.xml Edgar Link unprocessable
kaac-20171231_def.xml Edgar Link unprocessable
kaac-20171231_lab.xml Edgar Link unprocessable
kaac-20171231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending